A Comparative Study on CT-guided Radiofrequency Ablation and Targeted Therapy: Intervention Efficacy and Survival Rates in Lung Cancer Patients

被引：0
作者：
Zhao, Tianyu [1 ]
Zhang, Chunjing [1 ]
Dai, Hang [2 ]
Li, Jingyu [1 ]
Hao, Liguo [1 ]
Liu, Yanan [1 ]
机构：
[1] Qiqihar Med Univ, Med Technol Dept, Qiqihar 161006, Heilongjiang, Peoples R China
[2] Qiqihar Med Univ, Foreign Language Dept, 333,Bukui North St, Qiqihar 161006, Heilongjiang, Peoples R China
来源：
CURRENT MEDICAL IMAGING | 2025年 / 21卷
关键词：
Lung cancer; Radiofrequency ablation; Targeted therapy; Clinical efficacy; Immune response; Safety; Survival time; MANAGEMENT;
D O I：
10.2174/0115734056311827241211092432
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Objective The study aimed to evaluate the clinical efficacy of CT-guided radiofrequency ablation in conjunction with targeted therapy in lung cancer patients.Methods We retrospectively analyzed 80 lung cancer patients. They were stratified into the Observation Group (OG; n=40, treated with CT-guided radiofrequency ablation in conjunction with targeted therapy) and the Control Group (CG; n=40, treated solely with targeted therapy).Results The Overall Response Rate (ORR) and Disease Control Rate (DCR) in the OG group (70.00%, 95.00%) were significantly higher than those in the CG group (57.50%, 87.50%). After 6 weeks of treatment, the OG group had significantly lower levels of SCC, CEA, and CA125, higher CD4+ levels, and lower CD8+ levels, compared to the CG group. The 24-month follow-up survival rate of the OG group (47.50%) was significantly higher than that of the CG group (27.50%).Conclusion CT-guided radiofrequency ablation and targeted therapy have been proven effective in treating lung cancer.
引用
收藏
页数：9
相关论文
共 22 条
[11]   Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs [J].
Li, Jing ;
Zhong, Xianmei ;
Zhao, Yueshui ;
Shen, Jing ;
Pilapong, Chalermchai ;
Xiao, Zhangang .
MOLECULES, 2022, 27 (18)
[12]   Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials [J].
Miller, Laura J. ;
Douglas, Cara ;
McCullough, Fiona S. ;
Stanworth, Simon J. ;
Calder, Philip C. .
CLINICAL NUTRITION, 2022, 41 (10) :2135-2146
[13]   Current and Future Development in Lung Cancer Diagnosis [J].
Nooreldeen, Reem ;
Bach, Horacio .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
[14]   Immune-based Therapies for Non-small Cell Lung Cancer [J].
Rafei, Hind ;
El-Bahesh, Ehab ;
Finianos, Antoine ;
Nassereddine, Samah ;
Tabbara, Imad .
ANTICANCER RESEARCH, 2017, 37 (02) :377-387
[15]   Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors [J].
Rangamuwa, Kanishka ;
Leong, Tracy ;
Weeden, Clare ;
Asselin-Labat, Marie-Liesse ;
Bozinovski, Steven ;
Christie, Michael ;
John, Tom ;
Antippa, Phillip ;
Irving, Louis ;
Steinfort, Daniel .
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) :2842-2857
[16]   Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer [J].
Rath, Barbara ;
Plangger, Adelina ;
Hamilton, Gerhard .
CANCER DRUG RESISTANCE, 2020, 3 (02) :171-178
[17]   Multiple primary lung cancer: A literature review [J].
Romaszko, Anna M. ;
Doboszynska, Anna .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (05) :717-722
[18]   Cancer Progress and Priorities: Lung Cancer [J].
Schabath, Matthew B. ;
Cote, Michele L. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (10) :1563-1579
[19]   Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC) [J].
Tan, Aaron C. .
THORACIC CANCER, 2020, 11 (03) :511-518
[20]   Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137 [J].
Wang, Xi ;
Zhang, Guojun ;
Cheng, Zhe ;
Dai, Lingling ;
Jia, Liuqun ;
Jing, Xiaogang ;
Wang, Huan ;
Zhang, Rui ;
Liu, Meng ;
Jiang, Tianci ;
Yang, Yuanjian ;
Yang, Meng .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (06) :333-342
123